glp type 1 diabetes Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA GLP-1 Therapy for Diabetes and
Description
Liraglutide (3.0 mg, daily subcutaneous injection, n=22) or semaglutide (1.0 mg, weekly subcutaneous injection, n=18) was started 74.5 (51.0, 108.3) months after surgery following a weight regain of 14.7 (10.3, 19.6)%

Recent Findings Clinical trials have proven that the widely used GLP-1 analogues have pleotropic effects beyond those on weight and glucose metabolism and appear to confer favourable cardiovascular and renal outcomes

Danone is by your side on your GLP-1 weight loss journey with nutrient-rich, delicious food and beverages from our portfolio

How Do You Know If Semaglutide GLP-1 Is Working?
